164 related articles for article (PubMed ID: 15932737)
1. [Comparison of three FOBT protocols for colorectal cancer screening in Chinese--a multicenter study].
Li SR; Wang HH; Hu JC; Li N; Liu YL; Wu ZT; Zheng Y; Wang HH; Wu K; Ye H
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(10):697-700. PubMed ID: 15932737
[TBL] [Abstract][Full Text] [Related]
2. New immunochemical fecal occult blood test with two-consecutive stool sample testing is a cost-effective approach for colon cancer screening: results of a prospective multicenter study in Chinese patients.
Li S; Wang H; Hu J; Li N; Liu Y; Wu Z; Zheng Y; Wang H; Wu K; Ye H; Rao J
Int J Cancer; 2006 Jun; 118(12):3078-83. PubMed ID: 16425283
[TBL] [Abstract][Full Text] [Related]
3. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of mass screening for colorectal cancer with 'sequential fecal occult blood test' in an asymptomatic population. Multicenter GI Research Group of Beijing Area of PLA].
Zhonghua Zhong Liu Za Zhi; 1993 May; 15(3):230-3. PubMed ID: 8261874
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
7. Screening for colorectal cancer: the cost to find an advanced adenoma.
McGrath JS; Ponich TP; Gregor JC
Am J Gastroenterol; 2002 Nov; 97(11):2902-7. PubMed ID: 12425566
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16).
Chen LS; Liao CS; Chang SH; Lai HC; Chen TH
J Med Screen; 2007; 14(4):191-9. PubMed ID: 18078564
[TBL] [Abstract][Full Text] [Related]
10. Screening for gastrointestinal neoplasia: efficacy and cost of two different approaches in a clinical rehabilitation centre.
Manus B; Brägelmann R; Armbrecht U; Stolte M; Stockbrügger RW
Eur J Cancer Prev; 1996 Feb; 5(1):49-55. PubMed ID: 8664809
[TBL] [Abstract][Full Text] [Related]
11. [Preliminary report about the screening program for colorectal cancer by sequential fecal occult blood in Wuhan area for 4 years].
Lu ZM; Chen JG; Zhang YX; Wang Q; Xu J; Chen C; Yang R; Xiong F; Liu C; Peng XH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Sep; 12(5):474-6. PubMed ID: 19742337
[TBL] [Abstract][Full Text] [Related]
12. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Shiratori Y
Gastroenterology; 2005 Aug; 129(2):422-8. PubMed ID: 16083699
[TBL] [Abstract][Full Text] [Related]
14. Colorectal cancer screening for the natural population of Beijing with sequential fecal occult blood test: a multicenter study.
Li S; Nie Z; Li N; Li J; Zhang P; Yang Z; Mu S; Du Y; Hu J; Yuan S; Qu H; Zhang T; Wang S; Dong E; Qi D
Chin Med J (Engl); 2003 Feb; 116(2):200-2. PubMed ID: 12775229
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of immunochemical fecal occult blood test to small colorectal adenomas.
Morikawa T; Kato J; Yamaji Y; Wada R; Mitsushima T; Sakaguchi K; Shiratori Y
Am J Gastroenterol; 2007 Oct; 102(10):2259-64. PubMed ID: 17617203
[TBL] [Abstract][Full Text] [Related]
16. Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?
Hazazi R; Rozen P; Leshno M; Levi Z; Samuel Z; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2010 Feb; 31(4):523-33. PubMed ID: 19925498
[TBL] [Abstract][Full Text] [Related]
17. Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2009 Feb; 29(4):450-7. PubMed ID: 19035980
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of the optimal threshold of an automated immunochemical test for colorectal cancer screening: performances of immunochemical colorectal cancer screening.
Berchi C; Guittet L; Bouvier V; Launoy G
Int J Technol Assess Health Care; 2010 Jan; 26(1):48-53. PubMed ID: 20059780
[TBL] [Abstract][Full Text] [Related]
19. [Screening of high-risk group with colorectal cancer].
Xu AG; Yu ZJ; Zhong XH; Gan AH; Liu JH; Luo QY
Zhonghua Yi Xue Za Zhi; 2010 Jan; 90(2):116-8. PubMed ID: 20356496
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]